Sydney Cancer Centre Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2005
NCT00130442
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now